HAYWARD, Calif., Feb. 4, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Leerink Swann Global Healthcare Conference, at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013 at 11:30 am ET. Stephen J. Fanning , Chairman, President and Chief Executive Officer of Solta Medical, will review the company's business strategy and recent corporate events.
Solta will offer a live audio webcast of the presentation which may be accessed at the Investor Relations section of the Company's website at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry´s six premier brands: Thermage®, Fraxel®, Liposonix®, Isolaz®, CLARO® and Clear + Brilliant®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. The Liposonix system uses advanced high–intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat just beneath the skin in the treatment areas of the abdomen and flanks as a noninvasive, nonsurgical approach to aesthetic waist circumference reduction. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild–to–moderate inf
|SOURCE Solta Medical, Inc.|
Copyright©2012 PR Newswire.
All rights reserved